CRISPR and Genome Editing – Products

Refeyn has announced that mass photometry has been recognized by the US Pharmacopeia (USP) as a key orthogonal method for characterizing USP’s new AAV reference standards.

Cellular Origins has announced an international collaboration with Thermo Fisher Scientific to deliver full, robotic, 24/7 production of CGTs to the advanced therapy sector at the industrial scale.

The Sapio Platform is the first AI-native lab informatics solution to unify ELN, LIMS, and SDMS into a single platform, supporting R&D, clinical, and manufacturing labs by streamlining scientific workflows and standardizing data.

A no-code, science-aware ELN for modern labs. Sapio ELN supports structured and free-form experiments, AI-native assistance, and deep integration with LIMS and SDMS to streamline workflows and enable faster, more reproducible research

TQ Therapeutics acquires Juno Therapeutics GmbH, expanding its cell therapy platform and access to key intellectual property.

Telesis Bio and Regeneron collaborate to deploy the Gibson SOLA™ platform, enabling faster, automated gene synthesis to accelerate drug discovery.

CytoPak single-use bags support closed-system CGT manufacturing with weldable tubing, ready-to-use format, and optimized cytokine dosing—ensuring sterility, consistency, and scalability from research to commercial production.

Circio Holding ASA (OSE: CRNA), announces the presentation of new and strengthened in vivo data at the American Society of Gene and Cell Therapy (ASGCT) annual meeting 2025 in New Orleans, USA.

Bionova licenses ATUM’s Leap-In tech to speed up cell line development and streamline biologics manufacturing.

Atelerix partners with MineBio to bring its pioneering hydrogel-based cell preservation technology to China, enhancing biotech logistics and reducing costs.